Clinical trial registry record

Text Messaging to Reduce High-risk Alcohol Use Among Older Adults

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 2, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06319885
Last registry update
April 2, 2025
Status
Recruiting
Phase
Phase not reported
Sponsor
University of Southern Denmark
Enrollment
60
Countries
Denmark
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · PREVENTION · SINGLE
Evidence population
Human clinical study registration
Participants
60
Population
ALL · 55 Years to 80 Years
Duration
2024-04-15 to 2025-04-15
Intervention
Text messaging
Comparator
Assessment-only
Outcomes measured
High-risk alcohol use (yes/no) — Assessed at 12 weeks after baseline, alcohol use through the past seven days; WHOQOL-Bref (The World Health Organization Quality of Life Brief Version ) — Assessed at 12 weeks after baseline; OBSESSIVE-COMPULSIVE DRINKING SCALE (OCDS) — Through the past seven days, assessed at 12 weeks after baseline; Drinker Inventory of Consequences (DrInC-2R) — Through the past 14 days, assessed at 12 weeks after baseline; Frequency of alcohol use — Assessed at 12 weeks after baseline, alcohol use through the past seven days; Amount of alcohol use — Assessed at 12 weeks after baseline, alcohol use through the past seven days; Heavy drinking days — Assessed at 12 weeks after baseline, alcohol use through the past seven days; User evaluation (tailor-made) — Assessed at 12 weeks after baseline, through 12 weeks (the intervention period); PHQ-9 (Patient Health Questionnaire-9 ) — Assessed at 12 weeks after baseline, through the past 14 days
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Alcohol and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.